The AI infrastructure trade is roaring. Dell Technologies is today's standout — JP Morgan raised its target from $280 to $500 and upgraded the stock. The rally pushed Michael Dell past Mark Zuckerberg on the global wealth rankings, into sixth place. Short interest sits at just 6.7% of free float. Bears are not fighting this one.
The cybersecurity upgrade cycle is also live. Jefferies lifted targets on both CrowdStrike and Palo Alto Networks, to $775 and $300 respectively. NetApp earned target bumps from both JP Morgan and Barclays, with Barclays raising to $199.
On the short side, Wolfspeed sits at 131% short interest of free float with zero availability. That is an extreme positioning. Grindr saw its SI jump from 2.3% to 12.9% in a single week — a rapid and notable build.
Corcept Therapeutics presented major Phase 3 data at ASCO 2026 today. Its drug Lifyorli combined with nab-paclitaxel cut the risk of death by 35% versus chemo alone. That is a material survival benefit and a clear market-moving catalyst.
MannKind also got FDA approval for pediatric use of its inhaled insulin Afrezza. Short interest at 10.1% of free float means a fast repricing is possible.
Investors are racing to get SpaceX exposure ahead of a potential IPO. The FT reports $14 billion has poured into funds holding stakes in the rocket company. ETF providers are lining up new products. This is the biggest pre-IPO scramble in years.
Chevron's CEO warned oil prices will jump this summer as Strait of Hormuz tensions have removed up to 13 million barrels per day from global markets. Energy stocks are worth watching closely into June.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
